Evidence map›Paper›PMID 16207968›Full record

ArticleJournal of clinical microbiology2005

Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data.

Rune Aabenhus, Stephen L W On, Berit L Siemer, Henrik Permin, Leif P Andersen

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Markers for discriminatingCurrent research in microbial sciences · 2021
    Article
  2. Article
  3. Population Biology and Comparative Genomics of Campylobacter Species.Current topics in microbiology and immunology · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Complete Genome Sequence ofGenome announcements · 2017
    Article
  8. Frontiers in physiology · 2017
    Article
  9. Article
  10. Article
  11. Global Epidemiology of Campylobacter Infection.Clinical microbiology reviews · 2015
    Review
  12. Article
  13. Article
  14. Article
  15. Epsilonproteobacteria in humans, New Zealand.Emerging infectious diseases · 2012
    Article
  16. IBD-what role do Proteobacteria play?Nature reviews. Gastroenterology & hepatology · 2012
    Review
  17. Article
  18. Article
  19. Campylobacter concisus - A new player in intestinal disease.Frontiers in cellular and infection microbiology · 2012
    Review
  20. The clinical importance of emerging Campylobacter species.Nature reviews. Gastroenterology & hepatology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rune AabenhusDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Stephen L W On
Berit L Siemer
Henrik Permin
Leif P Andersen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Campylobacter concisus has been as frequently isolated from human diarrhea as the important enteropathogen Campylobacter jejuni, but it also occurs in the feces of healthy individuals. The role of C. concisus in human disease has been difficult to determine, since the species comprises at least two phenotypically indistinguishable but genetically distinct taxa (i.e., genomospecies) that may vary in pathogenicity. We examined 62 C. concisus strains by amplified fragment length polymorphism (AFLP) profiling and correlated the results with clinical data. All C. concisus strains gave unique AFLP profiles, and numerical analysis of these data distributed the strains among four clusters. The clustering was of taxonomic significance: two clusters contained, respectively, the type strain (of oral origin) and a reference strain (from diarrhea) of each of the known genomospecies. Genomospecies 2 strains were more frequently isolated from immunocompetent patients and/or patients without concomitant infections that presented with fever, chronic diarrhea, and gut inflammation than was genomospecies 1, clustering with the type strain of oral origin. Bloody diarrhea was recorded only with C. concisus genomospecies 2 infections. We identified two additional C. concisus genomospecies: genomospecies 3 comprised a single strain from an immunocompetent patient, and genomospecies 4 contained five isolates from severely immunodeficient patients, i.e., organ transplantation recipients or those with hematological malignancies. All genomospecies 4 strains were of the same protein profile group and failed to react with a C. concisus species-specific PCR assay based on 23S rRNA gene sequences: the taxonomic position of this group requires closer investigation. Campylobacter concisus is genetically and taxonomically diverse and contains at least four distinct genomospecies that may exhibit differences in their spectra of virulence potential.

Indexed as

Polymorphism, Restriction Fragment LengthAdolescentAdultAgedAged, 80 and overBacterial Typing TechniquesCampylobacterCampylobacter InfectionsChildChild, PreschoolDiarrheaFemaleHumansImmunocompetenceImmunocompromised HostInfant

Identifiers

PMID16207968
PMCPMC1248439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.